Rupal O’Quinn

885 total citations
21 papers, 423 citations indexed

About

Rupal O’Quinn is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Genetics. According to data from OpenAlex, Rupal O’Quinn has authored 21 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Rupal O’Quinn's work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Rupal O’Quinn is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Rupal O’Quinn collaborates with scholars based in United States, Canada and United Kingdom. Rupal O’Quinn's co-authors include Joseph R. Carver, Suparna C. Clasen, Bonnie Ky, Adam Waxman, Dan T. Vogl, Edward A. Stadtmauer, Adam D. Cohen, Alfred L. Garfall, Brendan M. Weiss and Wei‐Ting Hwang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Rupal O’Quinn

19 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rupal O’Quinn United States	9	237	205	133	108	63	21	423
Suparna C. Clasen United States	8	198 0.8×	179 0.9×	131 1.0×	106 1.0×	43 0.7×	16	378
Jan M. Horáček Czechia	15	273 1.2×	179 0.9×	65 0.5×	106 1.0×	58 0.9×	50	498
Beáta Mladosievičová Slovakia	11	147 0.6×	112 0.5×	82 0.6×	55 0.5×	23 0.4×	61	399
Leanne McCulloch United States	8	67 0.3×	202 1.0×	233 1.8×	261 2.4×	37 0.6×	16	459
Ghandi Damaj France	7	180 0.8×	129 0.6×	36 0.3×	65 0.6×	69 1.1×	14	375
Simone M. Mrotzek Germany	10	222 0.9×	174 0.8×	80 0.6×	15 0.1×	62 1.0×	15	414
Mayuko Inagaki United States	7	510 2.2×	47 0.2×	72 0.5×	135 1.3×	50 0.8×	9	759
Isaac Rhea United States	10	201 0.8×	51 0.2×	56 0.4×	22 0.2×	77 1.2×	22	280
Amir Y. Shaikh United States	10	369 1.6×	77 0.4×	35 0.3×	23 0.2×	73 1.2×	16	470
Wataru Shioyama Japan	10	149 0.6×	89 0.4×	62 0.5×	24 0.2×	17 0.3×	36	316

Countries citing papers authored by Rupal O’Quinn

Since Specialization

Citations

This map shows the geographic impact of Rupal O’Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupal O’Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupal O’Quinn more than expected).

Fields of papers citing papers by Rupal O’Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupal O’Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupal O’Quinn. The network helps show where Rupal O’Quinn may publish in the future.

Co-authorship network of co-authors of Rupal O’Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Rupal O’Quinn. A scholar is included among the top collaborators of Rupal O’Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupal O’Quinn. Rupal O’Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yen‐Chou, et al.. (2025). Cardiovascular safety outcomes of chronic lymphocytic leukemia treatments: A systematic and targeted literature review. Critical Reviews in Oncology/Hematology. 215. 104877–104877.

Adusumalli, Srinath, et al.. (2024). Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)—an analysis of an administrative health claims database. Cardio-Oncology. 10(1). 33–33. 2 indexed citations

Lee, Sang Ho, Lova Sun, Roger B. Cohen, et al.. (2023). Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation. International Journal of Radiation Oncology*Biology*Physics. 117(2). S169–S170. 1 indexed citations

Chen, Yen‐Chou, et al.. (2023). Impact of Baseline Comorbidities and Treatment on Cardiovascular (CV) Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Systematic Literature Review (SLR) of Interventional Trials and a Targeted Literature Review (TLR) of Real-World Observational Studies in CLL. Blood. 142(Supplement 1). 6539–6539.

Vidula, Mahesh, Rupal O’Quinn, Monika Sanghavi, et al.. (2022). Not All That Glitters Is Sarcoidosis: Septal Perforator Myocardial Infarction Mimicking Isolated Cardiac Sarcoidosis. Circulation Cardiovascular Imaging. 15(6). e014050–e014050. 1 indexed citations

Zhang, Robert, Kathleen M. Murphy, Peter Evans, et al.. (2021). Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series. Cardio-Oncology. 7(1). 13–13. 24 indexed citations

Rao, Vijay U., David J. Reeves, Atul Chugh, et al.. (2021). Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents. Journal of the American College of Cardiology. 77(21). 2693–2716. 41 indexed citations

Freyer, Craig W., Michael G. Fradley, Joseph R. Carver, et al.. (2021). Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(11). 934.e1–934.e6. 2 indexed citations

O’Quinn, Rupal, Victor A. Ferrari, Greg Hundley, et al.. (2021). Cardiac Magnetic Resonance in Cardio-Oncology. JACC CardioOncology. 3(2). 191–200. 15 indexed citations

10.

Adusumalli, Srinath, Jose Alvarez‐Cardona, Joshua D. Mitchell, et al.. (2020). Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology. Journal of Cardiovascular Translational Research. 13(3). 495–505. 5 indexed citations

11.

Kegelman, Timothy P., Varsha Jain, Steven J. Feigenberg, et al.. (2020). Cardiac Events Following Radiotherapy for Locally Advanced Non-Small Cell Lung Carcinoma: A Comparison between Photon and Proton Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). S138–S138. 1 indexed citations

12.

Hayek, Salim S., Sarju Ganatra, Carrie Lenneman, et al.. (2019). Preparing the Cardiovascular Workforce to Care for Oncology Patients. Journal of the American College of Cardiology. 73(17). 2226–2235. 39 indexed citations

13.

Arscott, W. Tristram, Priti Lal, Ronac Mamtani, et al.. (2018). Long-term Survival After Treating Cardiac Metastasis With Radiation and Immune Therapy: A Case Report. Cureus. 10(5). e2607–e2607. 8 indexed citations

14.

Clasen, Suparna C., et al.. (2017). Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm. Journal of Gastrointestinal Oncology. 8(6). 970–979. 45 indexed citations

15.

Zhao, Hang, Rupal O’Quinn, Marietta Ambrose, et al.. (2017). Contrast-Enhanced Echocardiography Has the Greatest Impact in Patients with Reduced Ejection Fractions. Journal of the American Society of Echocardiography. 31(3). 289–296. 13 indexed citations

16.

Carver, Joseph R., Rupal O’Quinn, Suparna C. Clasen, et al.. (2017). Persistence of ibrutinib-associated hypertension in CLL pts treated in a real-world experience.. Journal of Clinical Oncology. 35(15_suppl). 7525–7525. 7 indexed citations

17.

Waxman, Adam, Suparna C. Clasen, Wei‐Ting Hwang, et al.. (2017). Carfilzomib-Associated Cardiovascular Adverse Events. JAMA Oncology. 4(3). e174519–e174519. 200 indexed citations

18.

Waxman, Adam, Suparna C. Clasen, Alfred L. Garfall, et al.. (2017). Carfilzomib-associated cardiovascular adverse events: A systematic review and meta-analysis.. Journal of Clinical Oncology. 35(15_suppl). 8018–8018. 13 indexed citations

19.

O’Quinn, Rupal, et al.. (2016). Persistent PR segment change in malignant pericardial disease. Cardio-Oncology. 2(1). 6–6. 1 indexed citations

20.

Carver, Joseph R., Stephen J. Schuster, Jakub Svoboda, et al.. (2015). Bruton's Tyrosine Kinase Inhibition Is Associated with Manageable Cardiac Toxicity. Blood. 126(23). 4529–4529. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact